Comparison of histologic characteristics of chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wang, Hong ^a   Xue, Li ^a   Yan, Rong ^a   Zhou, Yin ^a   Wang, Ming Shan ^a   Cheng, Mei Juan ^a   Huang, Hai Jun ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALANINE TRANSAMINASE; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BIOPSY; CHINA; FEMALE; HEPATITIS B, CHRONIC; HUMANS; MALE; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84894056939     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080585     Document Type: Article

References (29)

1. Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL et al. (2009) National Institutes of Health Consensus Development Conference Statement: Management of hepatitis B. Ann Intern Med 150: 104-110. doi:10.7326/0003-4819- 150-2-200901200-00100. PubMed: 19124811.
2. Chen CJ, Yang HI, Su J, Jen CL, You SL et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73. doi:10.1001/jama.295.1.65. PubMed: 16391218. (Pubitemid 43042691)
3. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E et al. (2008) Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2: 263-283. doi:10.1007/s12072-008-9080-3. PubMed: 19669255.
4. Lok AS, McMahan BJ AASLD practice guidelines: chronic hepatitis B 2010. Available: http://www.aasld.org/practiceguidelines/.
5. Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM et al. (2005) Prognostic determinants for chronic hepatitis B in Asian: therapeutic implications. Gut 54: 1610-1614. doi:10.1136/gut.2005.065136. PubMed: 15871997. (Pubitemid 41531781)
6. Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH (2007) The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 47: 760-767. doi:10.1016/j.jhep.2007.07.022. PubMed: 17928090. (Pubitemid 350051121)
7. Chen EQ, Huang FJ, He LL, Bai L, Wang LC et al. (2010) Histological changes in Chinese chronical hepatitis B patients with ALT lower than two times upper limits of normal. Dig Dis Sci 55: 434-437.
8. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P et al. (2008) virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT . Gastroenterology 134: 1376-1384. doi:10.1053/j.gastro.2008.02.075. PubMed: 18471514. (Pubitemid 351615375)
9. Lin CL, Liao LY, Liu CJ, Yu MW, Chen PJ et al. (2007) Hepatitis B viral factors in HbeAg-negative carriers with persistently normal serum alanine aminotransferase levels. Hepatology 45: 1193-1198. doi: 10.1002/hep.21585. PubMed: 17464993.
10. Göbel T, Erhardt A, Herwig M, Poremba C, Baldus SE et al. (2011) High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in Central Europe. J Med Virol 83: 968-973. doi:10.1002/jmv.22048. PubMed: 21503908.
11. Chotiyaputta W, Degertekin B, McKenna BJ, Samala N, Fontana RJ et al. (2011) Characteristics of chronic hepatitis B patients who underwent liver biopsies. J Viral Hepat 18: 792-803. doi:10.1111/j.1365-2893.2010.01364.x. PubMed: 20726947.
12. Wu IC, Lai CL, Han SH, Han KH, Gordon SC et al. (2010) Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. Hepatology 51: 1185-1189. doi:10.1002/hep.23424. PubMed: 20044806.
13. Seto WK, Lai CL, Ip PP, Fung J, Wong DK et al. (2012) A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. PLOS ONE; 7: e32622. doi:10.1371/journal.pone.0032622. PubMed: 22389715.
14. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S et al. (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-10. doi: 10.7326/0003-4819-137-8-200210150-00027-w1. PubMed: 12093239.
15. Wang CC, Lim LY, Deubner H, Tapia K, Lau AW et al. (2008) Factors predictive of significant hepatic fibrosis in adults with chronic hepatitis B and normal serum ALT. J Clin Gastroenterol 42: 820-826. doi:10.1097/MCG. 0b013e318156feef. PubMed: 18458642.
16. Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229. doi: 10.1038/nri1573. PubMed: 15738952. (Pubitemid 40364823)
17. Lok AS (2002) Chronic hepatitis B. N Engl J Med 346: 1682-1683. doi: 10.1056/NEJM200205303462202. PubMed: 12037146.
18. Kim HC, Nam CM, Jee SH, Han KH, Oh DK et al. (2004) Normal serum aminotransferase concentration and risk of mortality from liver disease: prospective cohort study. BMJ 328: 983. doi:10.1136/bmj.38050.593634.63. PubMed: 15028636.
19. Papatheodoridis GV, Manolakopoulos S, Liaw YF, Lok A (2012) Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: A systematic review. J Hepatol 57: 196-202. doi:10.1016/j.jhep.2011.11.030. PubMed: 22450396.
20. Wong GL, Wong VW, Choi PC, Chan AW, Chim AM et al. (2009) Clinical factors associated with liver stiffness in hepatitis B antigen-positive chronic hepatitis B patients. Clin Gastroenterol Hepatol 7: 227-233. doi:10.1016/j.cgh.2008.10.023. PubMed: 19121647.
21. Puoti C (2013) How to manage HBeAg-negative infection with normal aminotransferase levels in clinical practice? Eur J Intern Med 24: 100-103. doi:10.1016/j.ejim.2012.10.013. PubMed: 23167981.
22. Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M et al. (1999) Serum thrombopoietin levels in patients with chronic hepatitis and lever cirrhosis. Am J Gastroenterol 94: 1918-1922. doi:10.1111/j.1572-0241.1999.01231. x. PubMed: 10406260. (Pubitemid 29315911)
23. Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R et al. (2001) Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic virus hepatitis. Br J Haematol 113: 590-595. doi:10.1046/j.1365-2141.2001.02824.x. PubMed: 11380442. (Pubitemid 32524375)
24. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P et al. (2006) A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 4: 936-962. doi:10.1016/j.cgh.2006.05.016. PubMed: 16844425. (Pubitemid 44118844)
25. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA et al. (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526. doi:10.1016/S0270-9139(03)80785-1. PubMed: 12883497. (Pubitemid 36919874)
26. Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME et al. (2009) The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacal Ther 29: 409-415.
27. Gui HL, Wang H, Yang YH, Wu YW, Zhou HJ et al. (2010) Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase. J Viral Hepat 17 Suppl 1: 44-50. doi:10.1111/j.1365-2893.2010.01270.x. PubMed: 20586933.
28. Chu CJ, Hussain M, Lok AS (2002) Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 122: 1756-1762. doi:10.1053/gast.2002.33588. PubMed: 12055581. (Pubitemid 34651418)
29. Tanwar S, Dusheiko G (2012) Is there any value to hepatitis B virus genotype analysis? Curr Gastroenterol Rep 14: 37-46. doi:10.1007/s11894-011- 0233-5. PubMed: 22105466.